497 related articles for article (PubMed ID: 28104302)
1. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
2. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; GafĂ R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M
Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
6. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
[TBL] [Abstract][Full Text] [Related]
7. Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2.
Felekkis KN; Koupepidou P; Kastanos E; Witzgall R; Bai CX; Li L; Tsiokas L; Gretz N; Deltas C
BMC Nephrol; 2008 Aug; 9():10. PubMed ID: 18721488
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
[TBL] [Abstract][Full Text] [Related]
9. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
12. c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation.
Elliott J; Zheleznova NN; Wilson PD
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C522-9. PubMed ID: 21508333
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
[TBL] [Abstract][Full Text] [Related]
14. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
15. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
16. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
Trant J; Sanchez G; McDermott JP; Blanco G
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 regulates STAT activity by a dual mechanism.
Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
[TBL] [Abstract][Full Text] [Related]
19. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
Ding H; Li LX; Harris PC; Yang J; Li X
Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]